Enhanced recovery for obese patients undergoing gynecologic cancer surgery.
Ross HarrisonMaria D IniestaBrandelyn PitcherPedro T RamirezKatherine CainAshley M SiverandGabriel MenaJavier LasalaLarissa A MeyerPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)
Neither post-operative length of stay nor the rate of serious complications differed significantly despite longer surgeries, greater blood loss, and more opioid use among obese patients. An ERAS program was safe, effective, and feasible for obese patients with suspected gynecologic cancer.
Keyphrases
- obese patients
- bariatric surgery
- papillary thyroid
- patients undergoing
- roux en y gastric bypass
- weight loss
- gastric bypass
- squamous cell
- adipose tissue
- metabolic syndrome
- type diabetes
- minimally invasive
- quality improvement
- squamous cell carcinoma
- childhood cancer
- risk factors
- acute coronary syndrome
- coronary artery disease
- atrial fibrillation